Literature DB >> 22906206

Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplant for adult acute myelogenous leukemia.

Neil Kogut, Ni-Chun Tsai, Sandra H Thomas, Joycelynne Palmer, Tanya Paris, Joyce Murata-Collins, Stephen J Forman.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22906206      PMCID： PMC3521076          DOI： 10.3109/10428194.2012.720375

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  9 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

2.  Extramedullary leukemic relapses following hematopoietic stem cell transplantation with nonmyeloablative conditioning.

Authors:  Guillermo J Ruiz-Argüelles; David Gómez-Almaguer; Jorge Vela-Ojeda; Amelia Morales-Toquero; Jóse David Gómez-Rangel; Miriam A García-Ruiz-Esparza; Briceida López-Martínez; Olga G Cantú-Rodríguez; César H Gutiérrez-Aguirrec
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

3.  High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation.

Authors:  D R Simpson; T J Nevill; J D Shepherd; H C Fung; D E Horsman; S H Nantel; L M Vickars; H J Sutherland; C L Toze; D E Hogge; H G Klingemann; S C Naiman; M J Barnett
Journal:  Bone Marrow Transplant       Date:  1998-08       Impact factor: 5.483

4.  Incidence of extramedullary relapse after haploidentical SCT for advanced AML/myelodysplastic syndrome.

Authors:  S Yoshihara; K Ikegame; K Kaida; K Taniguchi; R Kato; T Inoue; T Fujioka; H Tamaki; M Okada; T Soma; H Ogawa
Journal:  Bone Marrow Transplant       Date:  2011-08-22       Impact factor: 5.483

5.  Extramedullary sites of leukemia relapse after transplant.

Authors:  Isabel Cunningham
Journal:  Leuk Lymphoma       Date:  2006-09

6.  Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse.

Authors:  Melhem Solh; Todd E DeFor; Daniel J Weisdorf; Dan S Kaufman
Journal:  Biol Blood Marrow Transplant       Date:  2011-06-12       Impact factor: 5.742

7.  Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.

Authors:  M L Slovak; K J Kopecky; P A Cassileth; D H Harrington; K S Theil; A Mohamed; E Paietta; C L Willman; D R Head; J M Rowe; S J Forman; F R Appelbaum
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

8.  Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation.

Authors:  A N Békássy; J Hermans; N C Gorin; A Gratwohl
Journal:  Bone Marrow Transplant       Date:  1996-05       Impact factor: 5.483

9.  Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course.

Authors:  K-H Lee; J-H Lee; S-J Choi; J-H Lee; S Kim; M Seol; Y-S Lee; W-K Kim; E-J Seo; C-J Park; H-S Chi; J-S Lee
Journal:  Bone Marrow Transplant       Date:  2003-10       Impact factor: 5.483
  9 in total
  3 in total

1.  Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia.

Authors:  Anthony Stein; Joycelynne Palmer; Ni-Chun Tsai; Monzr M Al Malki; Ibrahim Aldoss; Haris Ali; Ahmed Aribi; Len Farol; Chatchada Karanes; Samer Khaled; An Liu; Margaret O'Donnell; Pablo Parker; Anna Pawlowska; Vinod Pullarkat; Eric Radany; Joseph Rosenthal; Firoozeh Sahebi; Amandeep Salhotra; James F Sanchez; Tim Schultheiss; Ricardo Spielberger; Sandra H Thomas; David Snyder; Ryotaro Nakamura; Guido Marcucci; Stephen J Forman; Jeffrey Wong
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-10       Impact factor: 5.742

2.  Circular RNA regulatory network reveals cell-cell crosstalk in acute myeloid leukemia extramedullary infiltration.

Authors:  Chengfang Lv; Lili Sun; Zhibo Guo; Huibo Li; Desheng Kong; Bingqi Xu; Leilei Lin; Tianjiao Liu; Dan Guo; Jin Zhou; Yinghua Li
Journal:  J Transl Med       Date:  2018-12-17       Impact factor: 5.531

3.  Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome.

Authors:  S D Goyal; M-J Zhang; H-L Wang; G Akpek; E A Copelan; C Freytes; R P Gale; M Hamadani; Y Inamoto; R T Kamble; H M Lazarus; D I Marks; T Nishihori; R F Olsson; R Reshef; D S Ritchie; W Saber; B N Savani; A Seber; T C Shea; M S Tallman; B Wirk; D W Bunjes; S M Devine; M de Lima; D J Weisdorf; G L Uy
Journal:  Bone Marrow Transplant       Date:  2015-04-27       Impact factor: 5.483
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.